| Abstrakt: |
A study conducted at Osmania University in Telangana, India, focused on the design, synthesis, and evaluation of novel 4H-chromene-7-azaindole-1,2,3-triazole hybrids as potential anticancer agents. The compounds were tested against various cancer cell lines, with some showing promising activity, particularly against HeLa cells. Molecular docking studies were also performed to assess the binding interactions of the compounds. This research has been peer-reviewed and provides valuable insights into the development of new anticancer agents. [Extracted from the article] |
